1 month retatrutide Retatrutide: The New Triple-Agonist Weight Loss Treatment Phase III retatrutide study demonstrates

Micro-dosing just means using smaller doses than what's recommended by the company when you read the package insert

Card Payment: Please notify us that you wish to cancel your order

When drug-induced obesity is documented, code E66.1 plus the appropriate adverse effect code from T36T50 with 5th/6th character A (initial encounter), D (subsequent), or S (sequela)

*Average weight loss based on 68 and 72 week clinical trials studying semaglutide (2.4 mg) and tirzepatide (10-15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related health condition, the average weight loss was 15% and 20% respectively

At the highest doses, Mounjaro produced an average weight loss of 20.9% of starting body weight compared to 14.9% for Wegovy

However, if you experience severe pain, numbness, or weakness, seek medical evaluation to rule out other causes